Skip to content

Optimization of the Isolation Protocol for Extracellular Vesicles (EVs) From Human Follicular Fluid

Optimization of the Isolation Protocol for Extracellular Vesicles (EVs) From Human Follicular Fluid

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06952751
Enrollment
4
Registered
2025-05-01
Start date
2025-07-22
Completion date
2029-12-01
Last updated
2026-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Extracellular Vesicles

Keywords

Extracellular vesicles, Isolation

Brief summary

Background: Extracellular vesicles (EVs) are membrane-bound vesicles found in all biological fluids, containing various regulatory molecules, including microRNAs (miRNAs). It has been suggested that the EVs in human follicular fluid (the fluid surrounding the oocyte within the ovary) play a crucial role in oocyte development through these miRNAs. However, several methods exist for isolating these EVs from follicular fluid. Before further research can be conducted on the pathophysiology and potential diagnostic and therapeutic applications of these EVs and their content, the optimal isolation technique must be determined for future studies. Each method has its advantages and disadvantages, and the purity and efficiency may vary between species and different biological fluids. There are only a limited number of studies comparing the various techniques for application in human follicular fluid. Objective: This study will compare the three most commonly used techniques for isolating EVs: size-based, sedimentation-based (differential ultracentrifugation), and buoyancy-based isolation techniques. Methodology: In this prospective study, follicular fluid will be collected from four patients undergoing transvaginal oocyte retrieval following ovarian stimulation at Ghent University Hospital. Patients over 40 years of age or with endometriosis, adenomyosis, or PCOS (polycystic ovarian syndrome) will not be included in this study. During the oocyte retrieval procedure, follicular fluid will be collected from 2-4 oocytes per patient. Since follicular fluid is not used in the patient's treatment (residual material), it does not affect the treatment. After collection, the three isolation techniques will be applied to each sample. The techniques will be compared in terms of purity (absence of contamination) and efficiency (EV concentration) using transmission electron microscopy, nanoparticle tracking analysis, and proteomic analyses.

Interventions

OTHERDifferential ultracentrifugation

Differential ultracentrifugation

OTHEROptiPrep™ density gradient ultracentrifugation

OptiPrep™ density gradient ultracentrifugation

OTHERSize-exclusion chromatography

Size-exclusion chromatography

OTHERCombined techniques

Combined techniques

Sponsors

University Hospital, Ghent
Lead SponsorOTHER
University Ghent
CollaboratorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

All collections of follicular fluid will be divided to test all three isolation methods under investigation.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Patients planned for an oocyte retrieval at Ghent University Hospital.

Exclusion criteria

* Diagnosis of endometriosis/adenomyosis * Diagnosis of PCOS (Polycystic Ovary Syndrome) * Macroscopic blood contamination at oocyte retrieval

Design outcomes

Primary

MeasureTime frameDescription
Purety3 monthsPurety of EV isolation

Secondary

MeasureTime frameDescription
Efficiency3 monthsEfficiency in terms of number of particles
RNA efficiency6 monthsEfficiency in terms of RIN scoring

Countries

Belgium

Contacts

CONTACTDominic Stoop, Prof. dr.
arg.studies@uzgent.be+ 329 332 34 42
CONTACTEva Decroos, Dr.
arg.studies@uzgent.be+329 332 67 56

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 2, 2026